2015 American Transplant Congress
Low Expanded Criteria Donor Listing Rates by Organ Procurement Organization Is Associated With Increased Differential in Waiting Time for Candidates Willing to Accept Marginal Organs in the US
Medicine, University of Virginia, Charlottesville, VA.
Organ procurement organization (OPO) listing rates for expanded criteria donor (ECD) kidneys vary greatly across the US. The goal of ECD listing is to shorten…2015 American Transplant Congress
Delayed Graft Function in Patients Receiving Alemtuzumab Induction Therapy
1The University of Toledo Medical Center, Toledo, OH; 2The Alliance for Paired Donation, Maumee, OH.
Alemtuzumab (Campath 1-H) is a humanized monoclonal antibody directed at the CD52 glycoprotein that is becoming more prevalent as a choice for induction. Delayed graft…2015 American Transplant Congress
Day of Week Influences Kidney Utilization
Department of Medicine, Columbia University Medical Center, New York, NY.
Background: From 2000 to 2013, 17% of all kidneys procured for transplantation from deceased organ donors in the United States were discarded. The high rate…2015 American Transplant Congress
Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism in Nonhuman Primates
Transplant Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Background: We have previously reported a successful induction of mixed chimerism and the long-term acceptance of renal allografts in MHC-mismatched nonhuman primates. In this study,…2015 American Transplant Congress
Where Does It End? Outcome of the Rejected Kidney Offers for Potential Renal Transplant and Their Outcome. A Single Centre Experience
Renal Medicine and Transplant Surgery, St Georges Healthcare NHS Trust, London, United Kingdom.
Background: Worldwide there are no uniformly acceptable deceased donor selection criteria for renal transplantation. There are national and international guidelines available based on which most…2015 American Transplant Congress
Kidney Transplant Function After Late Conversion to Belatacept (Nulojix®)
Introduction: In the long-term follow up of kidney transplants, chronic transplant nephropathy often in combination with CNI-toxicity is a major problem. With declining transplant function…2015 American Transplant Congress
Incisional Herniation Following Hand Assisted Laparoscopic Donor Nephrectomy: Incidence, Impact and Aetiology
Renal and Pancreatic Transplantation, Guy's Hospital, London, United Kingdom.
Introduction: Living kidney donor demographics, perioperative outcomes and data on renal function is recorded by national mandate. However other longer term and potentially significant surgical…2015 American Transplant Congress
The Impact of Donor and Recipient Weight Incompatibility on Outcomes in Renal Transplantation
Background: Kidney transplantation has been proposed as an accelerated model of nephron reduction resulting from the accumulation of repeated insults, both immunologic and non-immunologic events.…2015 American Transplant Congress
Clinical Significance of Estimated DSA MFI Values at 1,000 C1q MFI for Differentiation Between Harmful and Harmless DSA
INTRODUCTIONControl of chronic antibody mediated rejection (CAMR) is essential for further improvement of long-term graft survival. Early detection of de novo donor specific antibodies (DSA)…2015 American Transplant Congress
Inhibition of mTOR Modulates SLPI Expression: A Potential Role in Kidney Transplant Patients
Secretory leukocyte protease inhibitor (SLPI) is a serine protease inhibitor secreted by inflammatory and epithelial cells. It functions as an endogenous immunomodulatory, with antiinflammatory and…
- « Previous Page
- 1
- …
- 492
- 493
- 494
- 495
- 496
- …
- 531
- Next Page »